News

FMR LLC and Abigail P. Johnson filed Amendment No. 5 to their Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of common stock in Viking Therapeutics Inc. as of September 30, 2026.

FMR LLC and Abigail P. Johnson filed Amendment No. 10 to their beneficial ownership statement with respect to SkinHealth Systems Inc. (NASDAQ:SKIN) Class A Common Stock, disclosing a combined beneficial ownership position of 5,476,327 shares as of September 30, 2026, filed on November 5, …

FMR LLC and Abigail P. Johnson filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing a combined holding of 11,136,649.17 shares of Xenon Pharmaceuticals Inc. common stock as of September 30, 2026, representing 11.5% of the class.

FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 6,318,525 shares of Vor Biopharma Inc. common stock as of September 30, 2026.

FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of approximately 6.4% of the common stock of Tarsus Pharmaceuticals Inc. as of September 30, 2026.

FMR LLC and Abigail P. Johnson filed Amendment No. 6 to their Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of common stock in Wintrust Financial Corp as of September 30, 2026.

FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Victoria's Secret & Co as of September 30, 2026.